BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27044891)

  • 21. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.
    Neilsen PM; Noll JE; Mattiske S; Bracken CP; Gregory PA; Schulz RB; Lim SP; Kumar R; Suetani RJ; Goodall GJ; Callen DF
    Oncogene; 2013 Jun; 32(24):2992-3000. PubMed ID: 22797073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.
    Li M; Ng SS; Wang J; Lai L; Leung SY; Franco M; Peng Y; He ML; Kung HF; Lin MC
    Cancer Res; 2006 Feb; 66(3):1583-90. PubMed ID: 16452216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D.
    Santy LC; Casanova JE
    J Cell Biol; 2001 Aug; 154(3):599-610. PubMed ID: 11481345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARF6 promotes the formation of Rac1 and WAVE-dependent ventral F-actin rosettes in breast cancer cells in response to epidermal growth factor.
    Marchesin V; Montagnac G; Chavrier P
    PLoS One; 2015; 10(3):e0121747. PubMed ID: 25799492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe.
    Onodera Y; Nam JM; Horikawa M; Shirato H; Sabe H
    Nat Commun; 2018 Jul; 9(1):2682. PubMed ID: 29992963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the role of ADP-ribosylation factor 6 in tumor cell invasion and extracellular signal-regulated kinase activation.
    Hoover H; Muralidharan-Chari V; Tague S; D'Souza-Schorey C
    Methods Enzymol; 2005; 404():134-47. PubMed ID: 16413265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rab35 regulates Arf6 activity through centaurin-β2 (ACAP2) during neurite outgrowth.
    Kobayashi H; Fukuda M
    J Cell Sci; 2012 May; 125(Pt 9):2235-43. PubMed ID: 22344257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation-Inactivation Cycling of Rab35 and ARF6 Is Required for Phagocytosis of Zymosan in RAW264 Macrophages.
    Egami Y; Fujii M; Kawai K; Ishikawa Y; Fukuda M; Araki N
    J Immunol Res; 2015; 2015():429439. PubMed ID: 26229970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition.
    Lee MS; Kim HP; Kim TY; Lee JW
    Biochim Biophys Acta; 2012 Feb; 1823(2):514-23. PubMed ID: 22178131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
    Cao H; Xu E; Liu H; Wan L; Lai M
    Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling.
    Serwe G; Kachaner D; Gagnon J; Plutoni C; Lajoie D; Duramé E; Sahmi M; Garrido D; Lefrançois M; Arseneault G; Saba-El-Leil MK; Meloche S; Emery G; Therrien M
    Nat Commun; 2023 Jun; 14(1):3560. PubMed ID: 37322019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis.
    Hongu T; Yamauchi Y; Funakoshi Y; Katagiri N; Ohbayashi N; Kanaho Y
    Small GTPases; 2016 Apr; 7(2):47-53. PubMed ID: 26909552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 promotes migration of endothelial cells through the activation of ARF6 and the regulation of FAK activity.
    Daher Z; Noël J; Claing A
    Cell Signal; 2008 Dec; 20(12):2256-65. PubMed ID: 18814847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside.
    Sabe H; Hashimoto S; Morishige M; Hashimoto A; Ogawa E
    Cell Adh Migr; 2008; 2(2):71-3. PubMed ID: 19262097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell.
    Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z
    Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
    Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion.
    Marchesin V; Castro-Castro A; Lodillinsky C; Castagnino A; Cyrta J; Bonsang-Kitzis H; Fuhrmann L; Irondelle M; Infante E; Montagnac G; Reyal F; Vincent-Salomon A; Chavrier P
    J Cell Biol; 2015 Oct; 211(2):339-58. PubMed ID: 26504170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration.
    Palacios F; Price L; Schweitzer J; Collard JG; D'Souza-Schorey C
    EMBO J; 2001 Sep; 20(17):4973-86. PubMed ID: 11532961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinated Regulation of Intracellular Fascin Distribution Governs Tumor Microvesicle Release and Invasive Cell Capacity.
    Clancy JW; Tricarico CJ; Marous DR; D'Souza-Schorey C
    Mol Cell Biol; 2019 Feb; 39(3):. PubMed ID: 30397076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.